Gene therapy and biotechnology research by MeiraGTx

  • Dmytro Kharkov
  • 11.04.2026
MeiraGTx advances gene therapy initiative for Parkinson disease patients
MeiraGTx announced its commitment to improving care for individuals affected by Parkinson disease through its AAV-GAD program. The company expressed gratitude on World Parkinsons Day to ...
  • Viktoras Karapetjanc
  • 20.10.2025
MeiraGTx joins Chardan conference to discuss genetic medicine advances
MeiraGTx is set to participate in Chardan's 9th Annual Genetic Medicines Conference on October 21. The company's CEO, Alexandria Forbes, Ph.D., will address the latest advancements in genetic ...
  • Dmytro Kharkov
  • 17.10.2025
MeiraGTx platform boosts gene therapy efficiency with AI-driven promoter activity
At the American Society of Human Genetics 2025 conference, MeiraGTx showcased its AI-driven platform that can significantly enhance the efficiency of gene therapies. This cutting-edge technology ...
  • Olga Shendetskaya
  • 14.10.2025
MeiraGTx advances Parkinsons gene therapy with RMAT approval
MeiraGTx continues to make strides in medical innovation with its latest gene therapy for Parkinson's disease. The therapy, which involves a one-time brain injection, is being hailed as a ...